SCOTT KLEINERT: Open Payments
NPI 1841450244 · HUDSONVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$282 in 27 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $48 · 2025 $282
Food & beverage: $282
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $169 |
| Supernus Pharmaceuticals, Inc. | 1 | $27 |
| PFIZER INC. | 1 | $22 |
| Novo Nordisk Inc | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: VRAYLAR, UBRELVY, Qelbree, QULIPTA, ELIQUIS, Ozempic, MOUNJARO, ROTATEQ.
Industry payments across MI — which companies pay providers there.
